Legal Representation
Attorney
Robin Lightner Maisashvili
USPTO Deadlines
Next Deadline
2074 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250819)
Due Date
August 19, 2031
Grace Period Ends
February 19, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 19, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 19, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 3, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 3, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 28, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 6, 2025 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Apr 9, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Apr 9, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Apr 9, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 9, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Apr 9, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 17, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jan 17, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Oct 17, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 17, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 17, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 15, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 7, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 2, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Business consulting on the establishment, management, and operation of cancer treatment centers; promoting collaboration within the scientific and medical communities to achieve advances in healthcare; promoting public awareness of cancer, cancer research, cancer prevention and cancer treatment
First Use Anywhere:
Jan 1, 1988
First Use in Commerce:
Jan 1, 1988
Class 036
Charitable fundraising services
First Use Anywhere:
Jan 1, 1988
First Use in Commerce:
Jan 1, 1988
Class 044
Medical services; medical services, namely, cellular immunotherapy treatments; medical services, namely, human cancer treatment; providing medical information relating to immunotherapy; providing medical advice and consultancy regarding cancer therapies; medical and pharmaceutical consultation; medical services relating to cancer; dispensing of pharmaceuticals relating to cancer; immunobiology and immunotherapy medical services; medical services, namely, the treatment of cancer; medical consulting services, namely, consulting on the treatment of cancer; providing health information in the field of oncology, immunobiology, immunotherapy, and diseases; providing a web site featuring medical and health information; providing medical information, consultancy and advisory services; providing medical information relating to pharmaceuticals; providing information on health care via a telephone and the internet; providing information on cancer treatment; medical analysis services, namely, analysis of tumors, cancer and related medical conditions
First Use Anywhere:
Jan 1, 1988
First Use in Commerce:
Jan 1, 1988
Class 045
Providing patient advocate services in the treatment of diseases and disorders; providing a website featuring supportive personal stories on the subjects of health and cancer; providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional support
First Use Anywhere:
Jan 1, 1988
First Use in Commerce:
Jan 1, 1988
Additional Information
Other
AS TO UNIVERSITY OF TEXAS
Classification
International Classes
035
036
044
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"CANCER CENTER"